Helixon Biotechnology (suzhou) Co., Ltd
Clinical trials sponsored by Helixon Biotechnology (suzhou) Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug HXN6005 tested in healthy volunteers for first time Results expected Mar 2027 (estimated)
- New eczema drug HXN5003 enters first human safety trial Results expected Mar 2027 (estimated)